Blog
- September Study Links Prolonged Depo-Provera Use to Increased Risk of Brain Tumors
Nov 24, 2024
In September 2024, a significant study published in the journal Cancers revealed a troubling link between the prolonged use of Depo-Provera, an injectable contraceptive containing depot medroxyprogesterone acetate (dMPA), and an increased risk of developing cerebral meningiomas. The large-scale case-control study analyzed over 117,000 meningioma cases and more than one million matched controls using data spanning 2006–2022. It found that “injection exposure” to medroxyprogesterone acetate (Depo-Provera) was associated with a 53% increase in the risk...Read More - How to Sign Up for the Depo-Provera Meningioma Lawsuits
Nov 23, 2024
If you or a loved one has been diagnosed with meningioma after using Depo-Provera, you may be entitled to pursue legal action. Anapol Weiss, a nationally recognized personal injury law firm, has long been a leader in mass tort claims against some of the largest pharmaceutical companies, including Johnson & Johnson and Pfizer. In October, Anapol Weiss filed one of the first complaints specifically alleging that Depo-Provera, manufactured by Pfizer, caused the development of meningiomas...Read More - Women Representing Women: A Commitment to Empowerment A Journey of Advocacy
Nov 21, 2024
I have been a trial lawyer for twenty years. It has been a long road, but one where I have learned many valuable lessons. Most importantly, I have learned to take on clients and causes I believe in. As a woman and a mother, I am most proud of my work representing women. Fighting for Justice Many years ago, I began trying cases on behalf of women who were catastrophically injured by transvaginal mesh implants. These implants...Read More - A Guide to the History of Depo-Provera
Nov 21, 2024
Depo-Provera, a widely used injectable contraceptive, has a long and complex history of development, medical applications, and controversies. Initially hailed as a breakthrough in birth control, its use has been clouded by numerous studies and global debates about its safety. Recent developments, including a 2024 study linking long-term Depo-Provera use to an increased risk of meningiomas, have raised new questions about its safety. The Discovery of Medroxyprogesterone Acetate Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), was first synthesized...Read More - It’s Time for the Troubled Teen Industry to Face Reality
Nov 20, 2024
Paris Hilton's Testimony: A Catalyst for Change When most people think of Paris Hilton, they picture the glamorous socialite of The Simple Life. But Hilton’s teenage years were anything but glamorous. She has bravely come forward as a survivor of abuse in the troubled teen industry, shedding light on a dark reality that has been overlooked for far too long. Her courage is a wake-up call, demanding that we confront the systemic failures that have allowed...Read More - Roblox’s Safety Overhaul: Progress Arrives Too Late for Countless Families
Nov 19, 2024
Roblox, a platform widely celebrated for its popularity among children and teens, has long harbored a darker underbelly. Despite its recent announcement of new safety features aimed at protecting young users, these measures arrive after years of chilling reports detailing how predators, explicit content, and exploitation have infiltrated the platform. For too many families, Roblox became a digital hunting ground where children were exposed to unimaginable harm. While the new safety efforts are a step...Read More - Safety in the Skies: The Role of Our Courts
Nov 19, 2024
The article "Safety in the Skies: The Role of Our Courts," written by Anapol Weiss shareholder Larry E. Coben and published in The Legal Intelligencer, discusses the Ninth Circuit’s recent holding regarding the judiciary's role in adjudicating air traffic control (ATC) negligence claims following aviation tragedies. The Federal Aviation Administration oversees air traffic control, which is generally effective in preventing crashes during takeoff and landing. However, when accidents occur, courts must determine if ATC personnel acted...Read More - Ozempic and NAOIN – The American Academy of Ophthalmology Issues Statement
Nov 17, 2024
“A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness.” That is the first sentence of the American Academy of Ophthalmology (AAO) news release issued in response to the Harvard study published on July 3, 2024 in JAMA Ophthalmology: The eye condition, called non-arteritic anterior ischemic optic neuropathy (“NAION”), happens “when blood flow to the optic nerve...Read More - Advocacy with Empathy: The Power of Female Attorneys Representing Female Clients
Nov 13, 2024
As a female lawyer who is also a mom to two amazing boys, it quickly became apparent that the juggling act between career and motherhood would be difficult. As a mother, my priorities shifted, and I quickly realized that if I was going to maintain my career, I had to be passionate about what I was doing. At that time, litigations began emerging that solely or disproportionately affected women. In speaking to women who were...Read More - Litigating Prison Abuse: Addressing Assault Cases Behind Bars
Nov 12, 2024
The Reality of Prison Abuse Beyond Inmate Violence While prisons are commonly portrayed in the mainstream media and Hollywood as hotspots for inmate-on-inmate sexual and physical abuse, prison staff are also responsible for abusing inmates. A December 2022 bipartisan U.S. Senate report documented the sexual abuse of female inmates in federal prisons and the disproportionate number of sexual assaults female inmates face in comparison to their male counterparts. The report found that female inmates were abused in...Read More